About this Event
Single-cell and spatially resolved technologies have transformed numerous facets of biomedical research. Despite their revolutionary potential, the high costs and intricate experimental and analytical workflows associated with these technologies have restricted their widespread application in large patient cohort studies and their direct integration into routine clinical diagnostics and therapeutic decision-making. Focusing on hematological cancers, Simon Haas will showcase in his presentation how single-cell technologies can unravel complex disease mechanisms, improve cancer classification and may be harnessed for personalized medicine.
Event Venue & Nearby Stays
Clark-Kennedy Lecture Theatre, Whitechapel campus, Queen Mary Innovation Building, London, United Kingdom
GBP 0.00
